Indications and uses
For the temporary relief of burning and irritation due to dryness of the eye.
i-Drops LUBRICANT EYE DROPS
- Manufacturer
- GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED
- Effective date
- 2021-03-25
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:48:03
Label at a glance#
Producti-Drops LUBRICANT EYE DROPS
Active ingredientPOLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL
Label structure10 sections
Dosage and administration
Instill 1 or 2 drops in the affected eye(s) as needed .
Storage and handling
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Contacts and useful links#
Websitewww.global-pharma.com
www.global-pharma.com
www.global-pharma.comLabel contents#
Full prescribing information#
ACTIVE INGREDIENT
Polyethylene Glycol 400 0.4%
Propylene Glycol 0.3%
PURPOSE
Lubricant
Uses
For the temporary relief of burning and irritation due to dryness of the eye.
Warnings
For external use only.
Do not use
if this product changes color or becomes cloudy
if you are sensitive to any ingredient in this product
When using this product
• Do not touch tip of container to any surface to avoid contamination
• Replace cap after each use
Stop use and ask a doctor if
• You feel eye pain
• Changes in vision occur
• Redness or irritation of the eye(s) gets worse, persists or lasts more than 72 hours
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center.
Directions
Instill 1 or 2 drops in the affected eye(s) as needed .
Other information
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Inactive ingredients
Purified Water, Boric Acid, Hypromellose, Sodium Chloride, Potassium Chloride, Zinc Chloride, Calcium Chloride Dihydrate, Magnesium Chloride Hexahydrate. May contain Hydrochloric Acid and/or Sodium Hydroxide to adjust pH; Preservative, Benzalkonium Chloride.
Questions?
Call toll-free 1-800-572-6632, Weekdays, 7:00 AM – 5:30 PM EST.
SPL UNCLASSIFIED SECTION
Long lasting
Soothing dry eye therapy
Manufactured by :
Global Pharma Healthcare Pvt. Ltd.,
A-9, SIDCO Pharmaceutical Complex,
Alathur-603 110 - INDIA.
Packaging
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73921-005-15 | 2023-02-08 | C162847 | 48780-1 | f386c64a-2cff-0266-e053-dadaa90a7c1a | i-Drops LUBRICANT EYE DROPS |
| 73921-005-15 | 2023-01-30 | C162847 | 48780-1 | f386c64a-2cff-0266-e053-dadaa90a7c1a | i-Drops LUBRICANT EYE DROPS |
Products#
Every source-derived product name is available through these pages.
- i-Drops LUBRICANT EYE DROPS
- Polyethylene Glycol 400, Propylene Glycol
- POLYETHYLENE GLYCOL 400
- PROPYLENE GLYCOL
- WATER
- BORIC ACID
- HYPROMELLOSE, UNSPECIFIED
- SODIUM CHLORIDE
- POTASSIUM CHLORIDE
- ZINC CHLORIDE
- CALCIUM CHLORIDE
- MAGNESIUM CHLORIDE
- HYDROCHLORIC ACID
- SODIUM HYDROXIDE
- BENZALKONIUM CHLORIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 73921-005 | 73921-005-15 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POLYETHYLENE GLYCOL 400 | B697894SGQ | ACTIB |
| PROPYLENE GLYCOL | 6DC9Q167V3 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| BORIC ACID | R57ZHV85D4 | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| POTASSIUM CHLORIDE | 660YQ98I10 | IACT |
| ZINC CHLORIDE | 86Q357L16B | IACT |
| CALCIUM CHLORIDE | M4I0D6VV5M | IACT |
| MAGNESIUM CHLORIDE | 02F3473H9O | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f42b6382-0571-0e63-e053-2a95a90a211c | 16f9c75f-25d6-4374-a1ad-c8759beee365 | 2023-02-08 | Warnings | 16f9c75f-25d6-4374-a1ad-c8759beee365 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.